Nano Flow’s Zika Virus (ZIKV E) gold conjugate is based on a highly specific monoclonal antibody targeting the Zika Virus Envelope protein (ZIKV E). This conjugate has been validated as a detection antibody in lateral flow assays, ensuring sensitivity and specificity for ZIKV diagnostics. Importantly, the corresponding capture antibody is also available, providing developers with a complete pair solution for rapid assay design.
Zika Virus (ZIKV E) Gold Conjugate – 40 nm (Ref NF-ZIKVE-AU)

Thanks to its rigorous validation, this conjugate demonstrates no cross-reactivity with Dengue or Chikungunya viruses, ensuring reliability in differential diagnostics. Produced on Nano Flow’s highly spherical 40 nm gold nanoparticles (OD20), it guarantees high reproducibility, stability, and excellent visual signal in test and control lines.
Applications: Lateral flow assays (LF) and other immunoassay formats.
Certificate of Analysis: Available for each batch, including TEM, DLS, and UV-Vis characterization.
Technical Specifications
| Parameter | Specification |
|---|---|
| Antibody format | IgG1, kappa |
| Host | Mouse |
| Clonality | Monoclonal |
| Specificity | Recombinant Zika Virus Envelope Protein (ZIKV E) |
| Gold nanoparticle size | 40 nm |
| Cross-reactivity | None detected with Dengue Virus or Chikungunya Virus |
| Concentration of the gold conjugate | OD20 |
| Buffer | Borate, BSA 0.25%, NaN₃ 0.09%, pH 7.3 |
| Shelf life | 1 year |
| Available volumes | From 1 ml to 1 L+ |